INTRODUCTION
============

Low back pain (LBP) is a common disorder, which causes disability and widespread pain in elderly population (Bressler et al., 1999; [@b14-jer-14-6-1048]; [@b18-jer-14-6-1048]; [@b19-jer-14-6-1048]). It is the common secondary cause of seeing a doctor among patients who are at the age of 65 and older ([@b7-jer-14-6-1048]). The prevalence of LBP has increased to the age of 60 due to occupational exposure ([@b1-jer-14-6-1048]) and decreased to the age of 60 and over in terms of changing perceived pain and apathy ([@b2-jer-14-6-1048]; [@b3-jer-14-6-1048]; [@b8-jer-14-6-1048]; [@b9-jer-14-6-1048]; [@b16-jer-14-6-1048]; [@b21-jer-14-6-1048]; [@b23-jer-14-6-1048]). Eighty percent of older population has suffered form severe LBP and required long-term maintenance due to musculoskeletal system disorders. One third of this ratio constitutes from LBP and there is no adequate treatment, which is described for resolving pain in the elderly population.

Physical, psychological, and functional disorders accompanied with LBP and aging are increased impact of these problems. Unresolved LBP due to inadequate treatments and changes in perception increase the dependency on house and causes social isolation by leading emotional problems such as depression and anxiety.

In addition to medical, surgical and physiotherapy application, minimal invasive technics (MIT) have been used in management of LBP. Recently, we have observed that clinically geriatric population and their caregivers prefer MIT rather than surgery. Although, there have been studies related to MIT in geriatric patients, there is no an evidence based study related to physiotherapy added MIT in this population. So the aim of this study is to determine the effectiveness of physiotherapy application to geriatric patient with LBP who has received MIT on pain severity, functional disability and life quality.

MATERIALS AND METHODS
=====================

This retrospective study was performed with the patients' records from September 2015 to January 2017 after the approval of Institutional Review Board of the University of Hacettepe (approval number: GO 17/09-22). A total of 61 patients at the age of 60 and over were participated in the study. The inclusion criteria were to have pain for at least 3 months and undergone physiotherapy and rehabilitation. The exclusion criteria was to have neurologic disease additional to LBP, malignity, diabetes mellitus, dementia, organic cerebral dysfunction, and mental or cognitive impairments. According to patients' records and eligibility criteria, patients who received MIT and physiotherapy were labelled as group 1 and patients who received physiotherapy alone were labelled as group 2.

The routinely physiotherapy application for every patient was consisted of 20 min of hot-pack, myofascial stretching, muscle energy technics, and spinal stabilization exercises. Postisometric relaxations for Musculus Quadratus Lumborum, piriformis muscles were used as the muscle energy technics. Target muscle was located in the stretching position and the patients were asked to contract the muscle almost 8 sec up to submaximal. The spinal stabilization exercises started with diaphragm respiration and the cocontraction of transversus abdominus (TA) and core muscles, and moved on to intermediate and advanced level with the contraction of TA and Multifidus muscles, maintaining the contraction with different positions. Advancing in spinal stabilization exercise depends on the patient's capability of maintaining the positions. The patients had 12 sessions of physiotherapy twice a week during a 6-week period. One therapy session lasted almost 60 min.

Pain severity
-------------

The pain severity was rated by patients before the first and the last session of the physiotherapy with Visual Analog Scale. The distance between marked point and the origin is recorded as pain severity perceived by patient ([@b17-jer-14-6-1048]). The pain severity during activity and night was recorded from the files.

Functional disability
---------------------

Oswestry Disability Index (ODI) was used to measure functional disability levels This self-administered questionnaire consists of 10 items, each having a score of 0 to 5. ODI total scores ranges from 0 (no disability) to 50 (severe disability) ([@b22-jer-14-6-1048]).

Life quality
------------

Turkish version of Nottingham Health Profile (NHP) was used to measure the changes in perceived health status. It has six subgroups consisted of pain, physical activity, energy, sleep, social isolation, and emotional reactions which scored between 0 to 100 points. A high score in NHP indicates high level of impairment in health status ([@b13-jer-14-6-1048]).

Kinesiophobia
-------------

Turkish version of Fear Avoidance and Belief Questionnaire (FABQ) was used to measure the changes in fear avoidance behavior in patients with chronic LBP (CLBP). FABQ has 16-item scale, while first part is concerned to physical activity related fear avoidance, second part is demonstrated work related to fear avoidance beliefs. Each item replied by patient is a 7-point likert type scale which indicates completely disagree to completely agree ([@b12-jer-14-6-1048]).

RESULTS
=======

Patients' age and body mass index (BMI) were given in [Table 1](#t1-jer-14-6-1048){ref-type="table"} according to groups. There was no statistically difference between groups in terms of mean age and BMI (*P*\<0.05).

Clinical features of group 1 received MIT were shown in [Table 2](#t2-jer-14-6-1048){ref-type="table"}. According to [Table 2](#t2-jer-14-6-1048){ref-type="table"}, facet denervation was the most prevalent in MITs and radiofrequency ablation (RFA) was the common application when patients received more than two MITs.

Reduction of pain severity during activity, improvements in ODI, NHP, and BPS were recorded in terms of outcomes, which were applied before and after the treatment. There was no significant difference in measured outcomes except ODI and NHP (*P*\> 0.05). Before treatment, improvements in ODI and NHP were seen in favor of group 2 (*P*\<0.05). No significant differences were seen except NHP-physical sub parameter ([Table 3](#t3-jer-14-6-1048){ref-type="table"}).

Treatment (physiotherapy) effect of measured outcomes and additional group (MIT) effect on treatments were shown in [Table 4](#t4-jer-14-6-1048){ref-type="table"}. The only significant difference was in VAS activity, ODI and NHP energy and pain subparameter (*P*\<0.05). The only difference was recorded in NHP health sub parameter in favor of group 1, which is shown in right column of [Table 4](#t4-jer-14-6-1048){ref-type="table"} (*P*\<0.05).

DISCUSSION
==========

Current study was conducted to determine whether physiotherapy was effective in pain, functional status and quality of life in geriatric patients with CLBP who received MIT. It showed that both treatments had effective on the reduction in pain, functional restoration and quality of life. The results of the current study was similar with the literature in terms of the most common approaches were facet denervation and RFA.

According to the study, reductions in pain severity, disability, and costs associated with pain and opioid usage and increment in patient satisfaction after RFA are seen. Although positive improvements last for 6 months, they quietly decrease after 6 months ([@b5-jer-14-6-1048]). The repetitive radiofrequency applications---twice or even three times in 6 months---showed that it has short-term benefits. This result showed the necessity of treatments that should be supported by the physiotherapy applications.

There was no consensus related to the effectiveness of physiotherapy after MIT when it was applied. According to algologist suggestions, if no complication develops, physiotherapy can be applied after 3 days for epidural steroid injection, after 1 week for RFA and after 2 weeks for SELD. Based on our experience, we executed these periods for geriatric population. Muscle spasm can be seen after MIT especially in acute period and it causes LBP ([@b11-jer-14-6-1048]).

Although, pain severity is lesser in young adults compared to geriatric population due to apathy, muscle spasm after MIT is felt intensively in geriatric population. In acute stages of MIT, soft tissue technics are highly preferred by physiotherapists. In the current study, manual therapy included superficial heat agents, muscle relaxing and muscle-energy technics were applied and it helped increasing blood flow through muscles, resolving muscle spasm and breaks the pain-spasm-pain circle ([@b11-jer-14-6-1048]). It is also recommended that physiotherapy methods are effective in painful stages for resolving muscle spasm, decreasing pain severity and preparing patients for exercise therapy in geriatric patients with CLBP ([@b24-jer-14-6-1048]). The reduction of pain severity in current study can be interpreted thanks to the physiotherapy applications in both groups.

It was known that fear avoidance reactions and functional loss were developed associated with pain in geriatric patients with CLBP ([@b24-jer-14-6-1048]). Especially, fear of falling is highly correlated with older age ([@b20-jer-14-6-1048]). In all patients with CLBP who applied to Back and Neck Health Unit had functional disability at different stages, which caused performance loss and reduction in the quality of life. Literature has also supported the fact that geriatric patients who have back and neck disorders encountered problems with social role that causes social isolation ([@b10-jer-14-6-1048]; [@b15-jer-14-6-1048]).

The present study and literature also confirmed that the patients in both groups gained relaxation in connective tissue and functional restoration related to pain relief at the end of the therapy. Besides physiotherapy applications, being able to move around more comfortably, staying away from home environment and transferring to the hospital with car or public transport had positive influence on pain relief and functional restoration. It is not surprising that social isolation could be developed in geriatric patients who could not receive any treatment at hospital or home care. It is important to participate to active treatment process to prevent social isolation. In the current study, physiotherapist guided exercise program and regular follow-up had positive impact on increment of the life quality. Group 2 was found to be more effective particularly in terms of subparameters of the life quality. These results caused the fact that the patients who received MIT emerged physical activity limitation prevent the harvest side of MIT.

Baseline outcomes of the patient received MIT were more effective than the outcomes of the other group. The possible causes of this may be late application to the hospital, applying hospital with unbearable pain or letting the receive intervention at the last stage. Other possible cause of this may be that ideal patient for MIT was the one that had neuropathic pain and frequently evoked pain by physical activity ([@b6-jer-14-6-1048]).

Although baseline measures were higher in group 1, after physiotherapy application improvements recorded and the difference between groups ended. According to these results, the principal factor to gain improvement was physiotherapy applications. In other words, there was no additional improvement between patients who received MIT and patients who received physiotherapy alone.

Some limitations were noted for this study. Due to the first application center is algology department and referral to physiotherapy after interventions, there was no assessed outcome before MIT. In our country, health insurance companies paid for MIT after all noninvasive treatments such as physiotherapy and conventional approaches is tried and failed. So the study is lacking informative data about the patients received what kind of therapies till they reached MIT.

It is obvious that the current study has an important role on chronic pain management setting in geriatric population in terms of determining the effectiveness of two different methods. Physiotherapy applications were safe and feasible after MIT in geriatric patients with CLBP in terms of functional restoration, development of life quality and regaining older as a social individual. For further studies on the long-term pain relief, maintaining functional restoration and cost effectiveness calculation are needed to make precise comments.
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###### 

Demographic data of subjects

  Variable                    Group 1     Group 2   *P*-value
  --------------------------- ----------- --------- -----------
  Age (yr)                    71.8±4.8    70±5      0.710
  Body mass index (kg/m^2^)   23.7±11.3   24.5±12   0.903

Values are presented as mean±standard deviation.

Group 1, patients who received minimal invasive technics and physiotherapy; group 2, patients who received physiotherapy alone.

###### 

Clinical features of group 1

  Type                         One minimal invasive surgery   Two minimal invasive surgery   More than two minimal invasive surgery
  ---------------------------- ------------------------------ ------------------------------ ----------------------------------------
  Facet denervation            18 (50)                        2 (5.6)                        1 (2.8)
  Radiofrequency ablasion      3 (8.3)                        10 (27.8)                      7 (19.6)
  SELD                         9 (25)                         1 (2.8)                        2 (5.6)
  Epidural steroid enjection   3 (8.3)                        5 (13.9)                       6 (16.8)
  Epiduroscopy                 1 (2.8)                        2 (5.6)                        3 (8.4)
  SIJ enjection                1 (2.8)                        2 (5.6)                        0 (0)
  Discogel                     0 (0)                          1 (2.8)                        0 (0)

Values are presented as number (%).

Group 1, patients who received minimal invasive technics and physiotherapy; SELD, sacral epiduroscopic laser decompression; SIJ, sacroiliac joint.

###### 

Descriptive statistics and intragroup analyses

  Variable       Group 1       Group 2       *P*-value[a)](#tfn6-jer-14-6-1048){ref-type="table-fn"}   *P*-value[b)](#tfn7-jer-14-6-1048){ref-type="table-fn"}                                                                                                                                                   
  -------------- ------------- ------------- --------------------------------------------------------- --------------------------------------------------------- ------------- ------------ ------- ----------------------------------------------------- ------------------------------------------------------ -----------------------------------------------------
  VAS activity   6.8±2.4       4.5±3.1       −2.38                                                     0.017[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}       6.3±2.8       2.5±3        −2.04   0.041[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}   0.645                                                  0.448
                                                                                                                                                                                                                                                                                                                 
  VAS night      3.06±3.1      1.4±2.9       −1.61                                                     0.107                                                     2.7±3.2       3.3±2.7      −1.60   0.109                                                 0.571                                                  0.710
                                                                                                                                                                                                                                                                                                                 
  ODI            50±18.3       35.3±14.9     −3.41                                                     0.001[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}       39.1±14.5     30.2±13      −1.36   0.172                                                 0.023[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}    0.531
                                                                                                                                                                                                                                                                                                                 
  Nottingham                                                                                                                                                                                                                                                                                                     
   Energy        71.8±33.1     55.8±36.6     −2.69                                                     0.007[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}       45.2±37.8     43.0±36.0    −1.41   0.157                                                 0 .014[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}   0.372
   Pain          56.8±30.8     38.3±21.7     −2.20                                                     0.028[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}       50.1±28.3     40.1±22.9    −1.75   0.080                                                 0.654                                                  0.561
   Emotional     39.8±32.0     23.6±29.9     −1.85                                                     0.063                                                     25.8±30.9     16.0±18.0    −0.31   0.753                                                 0.120                                                  0.766
   Sleep         39.5±34.6     30.0±33.1     −1.22                                                     0.221                                                     26.0±28.6     13.1±14.1    −0.73   0.461                                                 0.192                                                  0.193
   Social        29.4±30.4     19.3±25.9     −0.762                                                    0.446                                                     10.8±22.1     5.5±10.1     −0.57   0.564                                                 0.006[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}    0.148
   Physical      48.4±17.7     44.3±14.1     −1.47                                                     0.141                                                     38.8±21.1     29.3±17.7    −1.29   0.196                                                 0.080                                                  0.037[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}
   Total         275.5±141.2   233.3±134.0   −1.33                                                     0.04[\*](#tfn8-jer-14-6-1048){ref-type="table-fn"}        190.7±143.4   152.4±91.9   −0.16   0.866                                                 0.033                                                  0.247
                                                                                                                                                                                                                                                                                                                 
  FABQ           23.2±23.3     20.4±5.3      −0.339                                                    −0.73                                                     15.2±7.1      12.4±8.1     0.96    0.334                                                 −0.73                                                  0.059

Group 1, patients who received minimal invasive technics and physiotherapy; group 2, patients who received physiotherapy alone; VAS, visual analogue scale; ODI, Oswestry Dısability Index; FABQ, Fear Avoidance Beliefs Questionnaire; BPS, Back Performance Scale.

Group 1 vs. group 2 prerehabilitation analyses.

Group 1 vs. group 2 postrehabilitation analyses.

*P*\<0.05.

###### 

Treatment (physiotherapy) and group effect

  Variable       Outcome change-treatment effect   Outcome change-group effect                                       
  -------------- --------------------------------- --------------------------------------------------------- ------- ------------------------------------------------------
  VAS activity   12.11                             0.002[\*](#tfn10-jer-14-6-1048){ref-type="table-fn"}      0.17    0.679
                                                                                                                     
  VAS night      4.19                              0.054                                                     0.33    0.570
                                                                                                                     
  ODI            17.32                             \<0.0001[\*](#tfn10-jer-14-6-1048){ref-type="table-fn"}   3.32    0.082
                                                                                                                     
  Nottingham                                                                                                         
   Energy        4.34                              0.050[\*](#tfn10-jer-14-6-1048){ref-type="table-fn"}      11.64   0.003[\*](#tfn10-jer-14-6-1048){ref-type="table-fn"}
   Pain          7.10                              0.016[\*](#tfn10-jer-14-6-1048){ref-type="table-fn"}      1.56    0.227
   Emotional     2.65                              0.121                                                     2.74    0.115
   Sleep         1.96                              0.178                                                     0.42    0.671
   Social        0.45                              0.508                                                     1.09    0.310
   Physical      3.41                              0.081                                                     0.20    0.657
   Total         0.73                              0.403                                                     0.58    0.455
                                                                                                                     
  FABQ           1.95                              0.180                                                     0.48    0.490

VAS, visual analogue scale; ODI, Oswestry Disability Index; FABQ, Fear Avoidance Beliefs Questionnaire.

*P*\<0.05.
